Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Collaborates with DiscoveRx to Offer GPCR Assays on LabChip

NEW YORK (GenomeWeb News) – Caliper Life Sciences said today it has struck a collaboration agreement under which it will bundle its LabChip systems with DiscoveRx’s G-protein-coupled receptor assays for drug research. 
 
The Hopkinton, Mass.-based company said the combined offering includes DiscoveRx’s PathHunter Beta Arrestin and cAMP Hunter assays.
 
Caliper CEO Kevin Hrusovsky said in a statement that the collaboration will enable the company to expand its offerings to “provide researchers with the ability to prosecute GPCR targets in a functional cellular assay for lead optimization and profiling.”
 

Caliper’s entry into the GPCR drug discovery market is “an opportunity with substantial potential due to the importance of GPCR drugs and the number of active R&D programs in neuroscience, cardiovascular, inflammation and other disease areas,” Hrusovsky added.

 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.